ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) Falls 1.06%, Turnover Reaches HKD 34.82 Million
Newtimespace News: As of 13:40 on April 20, ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) stood at HKD 15.820, down 1.06%. The ETF opened at HKD 15.980, with the latest net asset value (NAV) at HKD 15.926, a premium of 0.40%, a turnover of approximately HKD 34.824 million, and assets under management of approximately HKD 2.644 billion.
ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) closely tracks the Hang Seng Hong Kong Listed Biotech Index. The index covers 50 biotech companies listed in Hong Kong, focusing on pharmaceuticals, biotechnology, medical equipment and other fields, capturing innovative growth opportunities in the Hong Kong biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.